Nachrichtenticker zur Illumina Inc. Aktie

Trading-Desk starten

Freitag 08:03 Uhr

643 Trader online

mobile Apps

Börse:

Illumina Inc.

[WKN: 927079 | ISIN: US4523271090] Aktienkurse

183,690€ -16,71%

Echtzeit-Aktienkurs Illumina Inc.

Bid: 182,200€ Ask: 185,180€

Zeitraum wählen

Newsbot

Reuters

Marktberichte

Sonstiges

Standardwerte

Illumina (ILMN) Q2 Earnings and Revenues Lag Estimates

Illumina (ILMN) delivered earnings and revenue surprises of -9.52% and 4.73%, respectively, for the quarter ended June 2022. Do the…

Illumina Cuts FY Forecast; Shares Tank 22%

SAN DIEGO (dpa-AFX) - Shares of Illumina, Inc. (ILMN) tanked over 22% in extended trading session on Thursday after the…

Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook

Illumina Inc. shares sank more than 22% after hours Thursday after the gene-sequencing company swung to a loss in the…

Illumina Shares Plunge 22% After Hours On 2Q Loss, Slashed FY Outlook

Illumina Shares Plunge 22% After Hours On 2Q Loss, Slashed FY Outlook...…

Illumina drops 23% as company blames macro factors for Q2 miss

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Inc. Q2 Earnings Summary

SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: -$535 million in Q2 vs. $185 million…

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022

Revenue of $1.16 billion for Q2 2022, up 3% from Q2 2021, and up 5% on a constant currency basis…

Illumina Q2 Preview: 8th Consecutive EPS Beat in Store?

Just in its latest quarter, ILMN registered a solid 23% bottom-line beat....…

United Kingdom Non-Invasive Prenatal Testing Market Report 2022-2028 Featuring Natera, NIPD Genetics, Yourgene Health, Eurofins Biomnis, Illumina, PerkinsElmer, & BGI Diagnosis

DUBLIN, Aug. 10, 2022 /PRNewswire/ -- The "United Kingdom Non-Invasive Prenatal Testing Market and Forecasts 2022 - 2028" report has…

Will Illumina Q2 results bring positive surprise amid Grail merger woes?

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Synthetic Biology Market Global Outlook and Forecast 2022-2027: Expected Yearly Growth of 25% to 2027 Driven by Key Players Agilent, Codexis, Eurofins, Illumina, Novozymes & Thermo Fisher

DUBLIN, Aug. 8, 2022 /PRNewswire/ -- The Synthetic Biology Market - Global Outlook and Forecast 2022-2027 report has been added…

Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Access to Genomics

Speakers will outline critical steps needed to achieve health equity SAN DIEGO, Aug. 8, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:…

Illumina (ILMN) Q2 Earnings and Revenues Lag Estimates

Illumina (ILMN) delivered earnings and revenue surprises of -9.52% and 4.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

Den vollständigen Artikel können Sie lesen unter: http://www.zacks.com/stock/news/1967445/illumina-ilmn-q2-earnings-and-revenues-lag-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-1967445.

Hinweis: Die veröffentlichten Tradingsignale und Empfehlungen dienen lediglich der allgemeinen Information, sie sind keine Beratung im Sinne des Wertpapierhandelsgesetzes und stellen kein Angebot und keine Aufforderung zum Kauf, Halten oder Verkauf von Wertpapieren oder Derivaten dar. Sie entsprechen lediglich der aktuellen Einschätzung des verwendeten Handelssystems.

TraderFox GmbH: Impressum & Datenschutz - Allgemeine Geschäftsbedingungen - Cookie-Erklärung